Latest Breaking News On - Gastrointestinal cancers symposium - Page 16 : comparemela.com

News Category Global Banking & Finance Reviews Arcus Biosciences to Present Preliminary Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer at ASCO-GI Symposium Arcus Biosciences to Present Preliminary Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer at ASCO-GI Symposium Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that preliminary data from the ongoing dose-escalation portion of its ARC-8 Phase 1/1b study, evaluating the safety and tolerability of AB680, the first small-molecule CD73 inhibitor to enter the clinic, in combination with zimberelimab (anti-PD-1) and nab-paclitaxel plus gemcitabine (chemotherapy) in front-line metastatic pancreatic cancer will be presented in a poster session at the ASCO 2021 Virtual Gastrointestinal Cancers Symposium (ASCO GI) being held January 15

United statesKatherine bockArcus biosciences incArcus biosciencesGastrointestinal cancers symposiumBill grossmanChief medical officerPoster titlePancreatic cancer available dateProgress poster sessionColorectal cancer available datePrivate securities litigation reform actNat rev disInvest newClin cancerஒன்றுபட்டது மாநிலங்களில்